Winthrop Advisory Group’s AbbVie ABBV Stock Holding History

Winthrop Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Buy	4,944 +406	+9%	+$87.3K	0.08%	79
2026 Q1	$987K	Sell	4,538 -183	-4%	-$40.6K	0.08%	75
2025 Q4	$1.07M	Buy	4,721 +255	+6%	+$58.1K	0.09%	69
2025 Q3	$1.03M	Sell	4,466 -89	-2%	-$18.1K	0.09%	68
2025 Q2	$845K	Buy	4,555 +1,450	+47%	+$269K	0.08%	74
2025 Q1	$651K	Sell	3,105 -1,389	-31%	-$270K	0.08%	74
2024 Q4	$799K	Buy	4,494 +1,149	+34%	+$211K	0.1%	69
2024 Q3	$661K	Sell	3,345 -67	-2%	-$12.5K	0.08%	73
2024 Q2	$585K	Sell	3,412 -170	-5%	-$28.2K	0.08%	73
2024 Q1	$652K	Buy	3,582 +78	+2%	+$13.4K	0.09%	67
2023 Q4	$543K	Sell	3,504 -58	-2%	-$8.46K	0.08%	72
2023 Q3	$531K	Buy	3,562 +124	+4%	+$18.2K	0.09%	67
2023 Q2	$463K	Buy	3,438 +26	+0.8%	+$3.81K	0.07%	78
2023 Q1	$544K	Buy	3,412 +9	+0.3%	+$1.38K	0.1%	68
2022 Q4	$550K	Sell	3,403 -1,041	-23%	-$160K	0.1%	67
2022 Q3	$596K	Buy	4,444 +1	+0%	+$143	0.13%	56
2022 Q2	$680K	Buy	4,443 +1	+0%	+$153	0.16%	50
2022 Q1	$720K	Buy	4,442 +502	+13%	+$72.9K	0.15%	53
2021 Q4	$533K	Buy	3,940 +11	+0.3%	+$1.3K	0.11%	65
2021 Q3	$424K	Buy	3,929 +1,804	+85%	+$206K	0.09%	65
2021 Q2	$239K	Sell	2,125 -18	-0.8%	-$2.03K	0.05%	113
2021 Q1	$232K	Buy	2,143 +16	+0.8%	+$1.71K	0.06%	116
2020 Q4	$228K	Buy	+2,127	New	+$204K	0.06%	112

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Winthrop Advisory Group's ABBV Position: Q2 2026 in Review

Winthrop Advisory Group increased its AbbVie (ABBV) stake by 8.9% in Q2 2026, buying an estimated $87.3K and bringing the position to 4,944 shares worth $1.24M. The position accounts for 0.08% of the portfolio, ranked #79.

Winthrop Advisory Group first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Winthrop Advisory Group held 4,944 shares of AbbVie worth $1.24M as of Q2 2026.
Winthrop Advisory Group bought 406 AbbVie shares in Q2 2026, an estimated $87.3K.
AbbVie made up 0.08% of Winthrop Advisory Group's portfolio in Q2 2026, its #79 holding.
Winthrop Advisory Group first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Winthrop Advisory Group's 13F filing for Q2 2026, filed 17 Jul 2026.